clinical trial · NCT06590051

AMG 335 Expanded Access Program for IgG4-Related Disease

AMGEN →·—·approved for marketing

UPLIZNA

brief summary

Expanded access requests for AMG 335 may be considered for adult patients with a confirmed diagnosis of IgG4-related disease. To request access, use Responsible Party contact information provided in this record.

started

—

primary completion

—

completion

—

last updated

Sep 14, 2026

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol